Lu et al. found that parthenolide inhibits the transcriptional expression of the immune checkpoint molecule PD-L1 by targeting the phosphorylation of the transcription factor STAT3, thereby inhibiting the proliferation of GBM in mice. Here, STAT3 is linked to glioblastoma.